• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

enVVeno Medical Corporation - Common Stock (NQ:NVNO)

7.005 +0.135 (+1.97%)
Delayed Quote Updated: 3:49 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 102,114
Open 7.150
Bid (Size) 6.990 (100)
Ask (Size) 7.270 (100)
Prev. Close 6.870
Today's Range 6.910 - 7.610
52wk Range 6.520 - 25.97
Shares Outstanding 694,826
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium
November 02, 2026
Featured as an emerging technology and innovation in endovascular medicine, the presentation will highlight the potential of enVVe to address the significant unmet need in deep venous disease The... 
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Third Quarter 2026 Financial Results and Prepares to Treat First Patients in FDA-Approved TAVVE Pivotal Study
October 30, 2026
Initial 10-patient stage of U.S. pivotal study of the first-in-class enVVe non-surgical replacement venous valve on track to begin before year end Cash and investments of $18.5 million expected to fund... 
From enVVeno Medical Corporation
Via ACCESS Newswire

Performance

52-Week Range 73.0% below 52-week high
7.005
6.5252W Low 25.9752W High
1 Week 6.0% below 1-week high
6.521W Low 7.451W High

enVVeno Medical Corporation - Common Stock (NVNO) traded between $6.52 and $25.97 over the past 52 weeks and last traded at $7.00, 73.0% below its 52-week high. Over the past week it ranged between $6.52 and $7.45.

Past 12 Months
+3.9%
-12.5%
-34.5%
-34.4%
-42.8%
-71.8%
1W +$0.26
1M -$1.00
3M -$3.69
6M -$3.67
YTD -$5.25
1Y -$17.83

NVNO was -71.8% over the past year, -34.4% over six months, -42.8% year to date, +3.9% in the last week.

12 Months vs Market
NVNO
-71.8%
DIA
+9.1%
SPY
+10.4%
QQQ
+8.6%
IWM
+14.1%

Over the past 12 months NVNO returned -71.8% versus DIA (Dow) +9.1%, SPY (S&P 500) +10.4%, QQQ (Nasdaq 100) +8.6% and IWM (Russell 2000) +14.1%.

Volume & Liquidity 3.53× 3-mo avg
Today 102,114 3-mo avg 28.9K
1W
41.2K
1M
40.1K
3M
28.9K
6M
21.6K
YTD
20.6K
1Y
20.3K

NVNO most recently traded 102,114 shares against a 3-month average daily volume of 28.9K.

More News

Read More
News headline image
enVVeno Medical Releases New Episode of "WTF" Video Series Featuring CEO Rob Berman
October 21, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal Trial
October 02, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video Series
September 16, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-Demand
September 11, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Participates in the Virtual Investor 'Why Now' On-Demand Conference
August 27, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
Independent Health Economic Study Recently Published in Journal of Vascular Surgery Reports Economic Dominance of enVVeno Medical's Replacement Venous Valve Therapy Compared to Standard of Care Treatments
August 04, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
July 31, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment
July 15, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
July 07, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
June 22, 2026
From enVVeno Medical Corporation
Via ACCESS Newswire
News headline image
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
June 02, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
May 12, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
May 07, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
April 29, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
March 27, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 04, 2026
Via ACCESS Newswire
Let's take a look at the stocks that are in motion in today's session. ↗
January 30, 2026
Via Chartmill
What's going on in today's pre-market session ↗
January 15, 2026
Via Chartmill
News headline image
enVVeno Medical Announces Reverse Stock Split
January 15, 2026
Via ACCESS Newswire
News headline image
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
November 26, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
November 20, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
November 14, 2025
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session. ↗
November 14, 2025
Via Chartmill

Frequently Asked Questions

Is enVVeno Medical Corporation - Common Stock publicly traded?
Yes, enVVeno Medical Corporation - Common Stock is publicly traded.
What exchange does enVVeno Medical Corporation - Common Stock trade on?
enVVeno Medical Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for enVVeno Medical Corporation - Common Stock?
The ticker symbol for enVVeno Medical Corporation - Common Stock is NVNO on the Nasdaq Stock Market
What is the current price of enVVeno Medical Corporation - Common Stock?
The current price of enVVeno Medical Corporation - Common Stock is 7.005
When was enVVeno Medical Corporation - Common Stock last traded?
The last trade of enVVeno Medical Corporation - Common Stock was at 11/03/26 03:49 PM ET
What is the market capitalization of enVVeno Medical Corporation - Common Stock?
The market capitalization of enVVeno Medical Corporation - Common Stock is 4.87M
How many shares of enVVeno Medical Corporation - Common Stock are outstanding?
enVVeno Medical Corporation - Common Stock has 5M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap